Sepsis & infection

Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study

Br J AnaesthPublished Retrospective cohort study

Main findingResult — go to the resultHazard ratio 0.70 95% CI 0.61–0.79

Authors' conclusion

Magnesium sulfate use was associated with lower mortality in critically ill patients with sepsis.

Study context

Population
Adult critically ill patients with sepsis (MIMIC-IV database)6,052 matched
Participants
10,999 patients
Exposure
Magnesium sulfate use vs no use during ICU stay
  • Magnesium sulfate usen = 3,026
  • No usen = 3,026reference
Outcome
28-day all-cause mortality
Follow-up
28 days
Methodological detailspropensity-score matched (1:1), MIMIC-IV database, multivariable analyses
  • Propensity-score matched (1:1)
  • MIMIC-IV database
  • Multivariable analyses

Main finding

As reported in the abstract

Hazard ratio

0.70

95% CI 0.61–0.79

P < 0.001

Events by group

Magnesium sulfate use vs No use
HR 0.70 (95% CI 0.61–0.79); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
ICU mortality0.52 (0.42–0.64)P < 0.001
In-hospital mortality0.65 (0.55–0.77)P < 0.001
RRT0.67 (0.52–0.87)P = 0.002

28-day all-cause mortality, hypomagnesaemia (subgroup)

Lower mortality with magnesium sulfate use, hypomagnesaemia: HR (95% CI), P
0.64 (0.45-0.93), P=0.020
  • Propensity score matching (PSM) analysis

28-day all-cause mortality, normomagnesaemia (subgroup)

Lower mortality with magnesium sulfate use, normomagnesaemia: HR (95% CI), P
0.70 (0.61-0.80), P<0.001
  • PSM analysis

28-day all-cause mortality, entire cohort (sensitivity analysis)

Lower 28-day all-cause mortality in the entire cohort: HR (95% CI), P
0.62 (0.56-0.69), P<0.001
  • Sensitivity analysis

Original publication

Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study. Br J Anaesth. Published 7 September 2023. doi:10.1016/j.bja.2023.08.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.